Sfoglia per Autore "Papanicolaou, S."
Items 1-5 di 5
-
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study
Geitona, M.; Kousoulakou, H.; Ollandezos, M.; Athanasakis, K.; Papanicolaou, S.; Kyriopoulos, I. (2008)Background: To compare the costs and effects of paliperidone extended release (ER), a new pharmaceutical treatment for the management of schizophrenia, with the most frequently prescribed oral treatments in Greece (namely ... -
DIRECT COST OF TREATING PATIENTS WITH SCHIZOPHRENIA IN GREECE: REAL-WORLD DATA FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR)
Geitona, M.; Kousoulakou, C.; Ollandezos, M.; Papanicolaou, S.; Athanasakis, K.; Tsiantou, V.; Kyriopoulos, J. (2008) -
Erratum: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study (Annals of General Psychiatry)
Geitona, M.; Kousoulakou, H.; Ollandezos, M.; Athanasakis, K.; Kyriopoulos, I.; Papanicolaou, S. (2009) -
HELSPOR'S ASSESSMENT OF THE PHARMACEUTICAL POLICY REFORMS IN GREECE: COST-CONTAINMENT AND ECONOMIC EVALUATION CRITERIA
Kousoulakou, H.; Papanicolaou, S.; Geitona, M. (2009) -
Treatment pathways and cost assessment of schizophrenia in Greece: A primary analysis
Aggelopoulos, E.; Geitona, M.; Zaharakis, K.; Kakavas, P.; Karpouza, V.; Kesidou, S.; Kousoulakou, C.; Bilanakis, N.; Ollandezos, M.; Papamichael, E.; Papanicolaou, S.; Chaidemenos, A.; Chamogeorgakis, T.; Kyriopoulos, J. (2006)